Diagnostic accuracy of 99mTc-sestamibi SPECT/CT for detecting renal oncocytomas and other benign renal lesions: a systematic review and meta-analysis

[1]  M. Karlsson,et al.  Intra- and Interobserver Agreement of SUV SPECT Quantitative SPECT/CT Processing Software, Applied in Clinical Settings for Patients with Solid Renal Tumors , 2019, The Journal of Nuclear Medicine Technology.

[2]  M. Javadi,et al.  99mTc-sestamibi SPECT/CT for the diagnosis of benign renal oncocytomas and hybrid oncocytic/chromophobe tumors: Combined data from prospective trials and real-world clinical experience , 2019, European Urology Supplements.

[3]  M. Javadi,et al.  MP14-02 99MTC-SESTAMIBI SPECT/CT FOR THE DIAGNOSIS OF BENIGN RENAL ONCOCYTOMAS AND HYBRID ONCOCYTIC/CHROMOPHOBE TUMORS: COMBINED DATA FROM PROSPECTIVE TRIALS AND REAL-WORLD CLINICAL EXPERIENCE , 2019, Journal of Urology.

[4]  P. Bossuyt,et al.  Best practices for MRI systematic reviews and meta‐analyses , 2018, Journal of magnetic resonance imaging : JMRI.

[5]  M. Allaf,et al.  The role of molecular imaging in the characterization of renal masses , 2018, Current opinion in urology.

[6]  M. Javadi,et al.  Use of quantitative SPECT/CT reconstruction in 99mTc-sestamibi imaging of patients with renal masses , 2018, Annals of Nuclear Medicine.

[7]  David Moher,et al.  Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement , 2018, JAMA.

[8]  P. Pierorazio,et al.  Surgical histopathology for suspected oncocytoma on renal mass biopsy: a systematic review and meta‐analysis , 2017, BJU international.

[9]  M. Javadi,et al.  Characterization of indeterminate renal masses with molecular imaging: how do we turn potential into reality? , 2017, EJNMMI Research.

[10]  Mark W. Ball,et al.  Defining the Added Value of 99mTc-MIBI SPECT/CT to Conventional Cross-Sectional Imaging in the Characterization of Enhancing Solid Renal Masses , 2017, Clinical nuclear medicine.

[11]  M. Karlsson,et al.  Visual evaluation and differentiation of renal oncocytomas from renal cell carcinomas by means of 99mTc-sestamibi SPECT/CT , 2017, EJNMMI Research.

[12]  P. Humphrey,et al.  The 2016 WHO Classification of Tumours of the Urinary System and Male Genital Organs-Part A: Renal, Penile, and Testicular Tumours. , 2016, European urology.

[13]  Mark W. Ball,et al.  Prospective Evaluation of (99m)Tc-sestamibi SPECT/CT for the Diagnosis of Renal Oncocytomas and Hybrid Oncocytic/Chromophobe Tumors. , 2016, European urology.

[14]  Soo Min Koo,et al.  Imaging of carbonic anhydrase IX with an 111In-labeled dual-motif inhibitor , 2015, Oncotarget.

[15]  Mark W. Ball,et al.  Initial Experience Using 99mTc-MIBI SPECT/CT for the Differentiation of Oncocytoma From Renal Cell Carcinoma , 2015, Clinical nuclear medicine.

[16]  Susan Mallett,et al.  QUADAS-2: A Revised Tool for the Quality Assessment of Diagnostic Accuracy Studies , 2011, Annals of Internal Medicine.

[17]  E. Plimack,et al.  Coexisting hybrid malignancy in a solitary sporadic solid benign renal mass: implications for treating patients following renal biopsy. , 2014, The Journal of urology.

[18]  Lars Egevad,et al.  The International Society of Urological Pathology (ISUP) Vancouver Classification of Renal Neoplasia , 2013, The American journal of surgical pathology.

[19]  Steven P. Larson,et al.  Positron emission tomography/computed tomography identification of clear cell renal cell carcinoma: results from the REDECT trial. , 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[20]  F. Vera-Badillo,et al.  Chromophobe renal cell carcinoma: A review of an uncommon entity , 2012, International journal of urology : official journal of the Japanese Urological Association.

[21]  David C. Miller,et al.  Accuracy of determining small renal mass management with risk stratified biopsies: confirmation by final pathology. , 2012, The Journal of urology.

[22]  M. Selig,et al.  Use of Electron Microscopy in Core Biopsy Diagnosis of Oncocytic Renal Tumors , 2010, Ultrastructural pathology.

[23]  J. Grimshaw,et al.  An evidence-based practice guideline for the peer review of electronic search strategies. , 2009, Journal of clinical epidemiology.

[24]  Youngho Seo,et al.  Technological development and advances in single-photon emission computed tomography/computed tomography. , 2008, Seminars in nuclear medicine.

[25]  G. Zamboni,et al.  PEComas: the past, the present and the future , 2007, Virchows Archiv.

[26]  Stephanie Daignault,et al.  Rising incidence of small renal masses: a need to reassess treatment effect. , 2007, Journal of the National Cancer Institute.

[27]  Stephanie Daignault,et al.  Rising Incidence of Small Renal Masses: A Need to Reassess Treatment Effect , 2006 .

[28]  Johannes B Reitsma,et al.  Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews. , 2005, Journal of clinical epidemiology.

[29]  J. Cheville,et al.  Solid renal tumors: an analysis of pathological features related to tumor size. , 2003, The Journal of urology.

[30]  M. J. Van Every,et al.  Renal oncocytoma: preoperative diagnosis using technetium 99m sestamibi imaging. , 1996, Urology.

[31]  B. Holman,et al.  Subcellular distribution and analysis of technetium-99m-MIBI in isolated perfused rat hearts. , 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[32]  J. J. Park,et al.  Small (< 4 cm) Renal Tumors With Predominantly Low Signal Intensity on T2-Weighted Images: Differentiation of Minimal-Fat Angiomyolipoma From Renal Cell Carcinoma. , 2017, AJR. American journal of roentgenology.

[33]  B. Hasegawa,et al.  Technological Development and Advances in SPECT/CT , 2011 .

[34]  L. Truong,et al.  Renal epithelial neoplasms: the diagnostic implications of electron microscopic study in 55 cases. , 2002, Human pathology.